X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB J.B.CHEMICALS UNICHEM LAB/
J.B.CHEMICALS
 
P/E (TTM) x 282.0 19.2 1,471.2% View Chart
P/BV x 0.6 2.6 25.0% View Chart
Dividend Yield % 2.6 0.1 1,749.2%  

Financials

 UNICHEM LAB   J.B.CHEMICALS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
J.B.CHEMICALS
Mar-16
UNICHEM LAB/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs382318 120.1%   
Low Rs234200 117.3%   
Sales per share (Unadj.) Rs116.3148.0 78.6%  
Earnings per share (Unadj.) Rs-18.919.1 -99.1%  
Cash flow per share (Unadj.) Rs-11.723.9 -49.0%  
Dividends per share (Unadj.) Rs5.000.50 1,000.0%  
Dividend yield (eoy) %1.60.2 840.1%  
Book value per share (Unadj.) Rs381.0128.9 295.5%  
Shares outstanding (eoy) m70.3484.82 82.9%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.61.7 151.5%   
Avg P/E ratio x-16.313.6 -120.1%  
P/CF ratio (eoy) x-26.210.8 -242.8%  
Price / Book Value ratio x0.82.0 40.3%  
Dividend payout %-26.42.6 -1,008.6%   
Avg Mkt Cap Rs m21,66821,951 98.7%   
No. of employees `0002.32.7 83.4%   
Total wages/salary Rs m2,0061,841 109.0%   
Avg. sales/employee Rs Th3,587.84,590.9 78.2%   
Avg. wages/employee Rs Th880.0673.4 130.7%   
Avg. net profit/employee Rs Th-583.7592.1 -98.6%   
INCOME DATA
Net Sales Rs m8,18012,551 65.2%  
Other income Rs m610542 112.6%   
Total revenues Rs m8,79013,093 67.1%   
Gross profit Rs m-1,3202,055 -64.3%  
Depreciation Rs m505412 122.5%   
Interest Rs m8096 83.7%   
Profit before tax Rs m-1,2952,088 -62.0%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m33469 7.1%   
Profit after tax Rs m-1,3311,619 -82.2%  
Gross profit margin %-16.116.4 -98.6%  
Effective tax rate %-2.622.5 -11.5%   
Net profit margin %-16.312.9 -126.2%  
BALANCE SHEET DATA
Current assets Rs m23,3187,778 299.8%   
Current liabilities Rs m4,6354,358 106.4%   
Net working cap to sales %228.427.2 838.3%  
Current ratio x5.01.8 281.9%  
Inventory Days Days12255 222.7%  
Debtors Days Days12180 151.8%  
Net fixed assets Rs m8,1635,713 142.9%   
Share capital Rs m141170 83.0%   
"Free" reserves Rs m26,66010,547 252.8%   
Net worth Rs m26,80110,937 245.0%   
Long term debt Rs m30-   
Total assets Rs m31,89015,574 204.8%  
Interest coverage x-15.222.8 -66.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.30.8 31.8%   
Return on assets %-3.911.0 -35.6%  
Return on equity %-5.014.8 -33.6%  
Return on capital %-4.520.0 -22.8%  
Exports to sales %048.7 0.0%   
Imports to sales %07.1 0.0%   
Exports (fob) Rs mNA6,115 0.0%   
Imports (cif) Rs mNA889 0.0%   
Fx inflow Rs m4,3566,169 70.6%   
Fx outflow Rs m01,285 0.0%   
Net fx Rs m4,3564,884 89.2%   
CASH FLOW
From Operations Rs m-1,1231,397 -80.4%  
From Investments Rs m16,487-320 -5,147.3%  
From Financial Activity Rs m-8,811-1,196 736.9%  
Net Cashflow Rs m6,552-102 -6,404.7%  

Share Holding

Indian Promoters % 50.1 55.4 90.4%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 15.1 3.4 445.4%  
FIIs % 3.0 3.9 76.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 37.0 85.7%  
Shareholders   20,176 30,437 66.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   NOVARTIS  TORRENT PHARMA  FRESENIUS KABI ONCO.  CIPLA  ABBOTT INDIA  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Realty and IT Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector and IT sector.

Related Views on News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

This is Why You Need to Buy Small Cap Stocks Now(The 5 Minute Wrapup)

Mar 15, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Mar 20, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS